Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.
Fulltext:
52476.pdf
Embargo:
until further notice
Size:
340.0Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2007Source
Head and Neck : Journal for the Sciences and Specialties of the Head and Neck, 29, 6, (2007), pp. 591-604ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Radiation Oncology
Otorhinolaryngology
Journal title
Head and Neck : Journal for the Sciences and Specialties of the Head and Neck
Volume
vol. 29
Issue
iss. 6
Page start
p. 591
Page end
p. 604
Subject
DCN 1: Perception and Action; DCN 2: Functional Neurogenomics; ONCOL 3: Translational research; UMCN 1.3: Tumor microenvironmentAbstract
BACKGROUND: Hypoxia and tumor cell proliferation are important factors determining the treatment response of squamous cell carcinomas of the head and neck. Successful approaches have been developed to counteract these resistance mechanisms although usually at the cost of increased short- and long-term side effects. To provide the best attainable quality of life for individual patients and the head and neck cancer patient population as a whole, it is of increasing importance that tools be developed that allow a better selection of patients for these intensified treatments. METHODS: A literature review was performed with special focus on the predictive value and clinical relevance of endogenous hypoxia-related markers. RESULTS: New methods for qualitative and quantitative assessment of functional microenvironmental parameters such as hypoxia, proliferation, and vasculature have identified several candidate markers for future use in predictive assays. Hypoxia-related markers include hypoxia inducible factor (HIF)-1alpha, carbonic anhydrase IX, glucose transporters, erythropoietin receptor, osteopontin, and others. Although several of these markers and combinations of markers are associated with treatment outcome, their clinical value as predictive factors remains to be established. CONCLUSIONS: A number of markers and marker profiles have emerged that may have potential as a predictive assay. Validation of these candidate assays requires testing in prospective trials comparing standard treatment against experimental treatments targeting the related microregional constituent.
This item appears in the following Collection(s)
- Academic publications [245263]
- Electronic publications [132514]
- Faculty of Medical Sciences [93208]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.